Flow Cytometry Antibodies

Mouse monoclonal (7H12) to E Cadherin, could be used for WB, IHC and Flow.Application WB: 1/500-1/2000 IHC: 1/200-1/1000Flow: 1/200-1/400ELISA: 1/10000PurityProtein G purified.Protein FunctionCadherins are calcium-dependent cell adhesion proteins.

Mouse monoclonal (7H12) to E Cadherin, could be used for WB, IHC and Flow.Application WB: 1/500-1/2000 IHC: 1/200-1/1000Flow: 1/200-1/400ELISA: 1/10000PurityProtein G purified.Protein FunctionCadherins are calcium-dependent cell adhesion proteins.

Enfortumab (anti-NECTIN4) is a monoclonal antibody targeting Nectin-4. Enfortumab (anti-NECTIN4) can used for researching urothelial cancer.Purity&gt95% (SDS-PAGE&ampSEC)Endotoxin Level&lt 1.0EU/mg

Enfortumab (anti-NECTIN4) is a monoclonal antibody targeting Nectin-4. Enfortumab (anti-NECTIN4) can used for researching urothelial cancer.Purity&gt95% (SDS-PAGE&ampSEC)Endotoxin Level&lt 1.0EU/mg

Enfortumab (anti-NECTIN4) is a monoclonal antibody targeting Nectin-4. Enfortumab (anti-NECTIN4) can used for researching urothelial cancer.Purity&gt95% (SDS-PAGE&ampSEC)Endotoxin Level&lt 1.0EU/mg

Enfortumab (anti-NECTIN4) is a monoclonal antibody targeting Nectin-4. Enfortumab (anti-NECTIN4) can used for researching urothelial cancer.Purity&gt95% (SDS-PAGE&ampSEC)Endotoxin Level&lt 1.0EU/mg

ApplicationWB: 1/2,000-1/50,000 Predicted molecular weight: 37 kDaFlow: 0.016 μg/mL-0.5 μg/mLDescriptionHas both glyceraldehyde-3-phosphate dehydrogenase and nitrosylase activities, thereby playing a role in glycolysis and nuclear functions,

ApplicationWB: 1/2,000-1/50,000 Predicted molecular weight: 37 kDaFlow: 0.016 μg/mL-0.5 μg/mLDescriptionHas both glyceraldehyde-3-phosphate dehydrogenase and nitrosylase activities, thereby playing a role in glycolysis and nuclear functions,

ApplicationWB: 1/2,000-1/50,000 Predicted molecular weight: 37 kDaFlow: 0.016 μg/mL-0.5 μg/mLDescriptionHas both glyceraldehyde-3-phosphate dehydrogenase and nitrosylase activities, thereby playing a role in glycolysis and nuclear functions,

ApplicationWB: 1/2,000-1/50,000 Predicted molecular weight: 37 kDaFlow: 0.016 μg/mL-0.5 μg/mLDescriptionHas both glyceraldehyde-3-phosphate dehydrogenase and nitrosylase activities, thereby playing a role in glycolysis and nuclear functions,

Gemtuzumab (anti-CD33) is a monoclonal antibody targeting CD33 antigen, which present on leukemic myeloblasts of acute myeloid leukemia (AML). Gemtuzumab (anti-CD33) can be used for synthesis of antibody-drug conjugate (ADC), Gemtuzumab ozogamicin.

Gemtuzumab (anti-CD33) is a monoclonal antibody targeting CD33 antigen, which present on leukemic myeloblasts of acute myeloid leukemia (AML). Gemtuzumab (anti-CD33) can be used for synthesis of antibody-drug conjugate (ADC), Gemtuzumab ozogamicin.